![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
Found in translation
By PerkinElmer
The cost of drug production has soared into the billions, presenting a huge barrier to companies hoping to market new medicines and creating a pressing need for more efficient development techniques. PerkinElmer’s Jens Hoefkens and Daniel Weaver discuss how translational medicine is simultaneously reducing expenses and improving the health of patients.
![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)